Kate Flavin McKinley

Kate Flavin McKinley currently serves as Chief Business Officer at Rani Therapeutics and holds a position as Board Director, Chair of the Investment Committee, and Chair of the Compensation Committee at Maxwell Biosciences. Previously, Kate founded and served as Chief Executive Officer at Spark Outcomes and held the role of Chief Executive Officer at Elevar Therapeutics, which was acquired by HLB Co., Ltd. Kate's experience also includes significant leadership roles at Hainan Pactil Advanced Therapeutics Company LTD and Dendreon, where Kate focused on marketing and brand strategy for immunotherapy. A former executive at AbbVie, Kate held multiple senior roles culminating as Head of Sales for the Urology, Oncology & Gynecology Franchise. Kate's educational background includes an MBA in Marketing Strategy from The University of Tulsa and a Certificate in Corporate Governance from Wharton Executive Education.